Ossium Health, a pioneering bioengineering firm dedicated to creating the world's inaugural repository of donor organ bone marrow, has joined forces with the National Marrow Donor Program? (NMDP)/Be The Match?, an esteemed global entity committed to saving lives through cellular therapy.

Bayer has announced a further commitment to its clinical development program known as MOONRAKER, which is focused on investigating the potential of Kerendia? (finerenone) as a treatment for heart failure (HF).

LivaNova PLC, a leading company in the field of medical technology, has announced today that it has obtained clearance from the U.S. Food and Drug Administration (FDA) through its 510(k) submission, as well as the CE Mark.

Humboldt General Hospital is pleased to unveil an exciting new collaboration with Western Surgical Group, marking a significant enhancement in healthcare offerings for Winnemucca and its neighboring communities.

Innovative Health Diagnostics, known as IHDLab, a registered laboratory under CLIA and FDA, has just introduced LabFlow, a cutting-edge API platform as part of its Diagnostics-as-a-Service (DaaS) offering.

Mindray, a prominent global provider of advanced medical device solutions, has introduced enhancements to its A7 and A5 anesthesia systems as part of the A Series Anaesthesia portfolio.

Compassion Behavioral Health, a prominent leader in providing comprehensive treatments for mental health and addiction, takes immense pride in announcing the inauguration of its cutting-edge facility on Mayo St. in Hollywood, FL.

3B Scientific, a prominent manufacturer and distributor of medical simulation products and anatomical models for healthcare education, has officially announced its acquisition of iNNOGING Medical.

Curant Health, a prominent organization focused on patient support based on outcomes, has announced a strategic collaboration with BioCare Inc.'s subsidiaries

Clarity Pharmaceuticals (ASX: CU6), a clinical-stage radiopharmaceutical company committed to advancing next-generation products that enhance treatment outcomes for both pediatric and adult cancer patients